Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

American Express Company (AXP): This Credit Card and Travel Company Still Has Growing To Do

Page 1 of 2

With the strong gains in financials so far this year, it may seem like the sector may be running out of gas. While this may be true for some companies, there are still bright spots to be found, and the truth is that the financial sector is still one of the cheapest in the market. One of my favorite companies in the space, and one that I still believe to be grossly undervalued, is American Express Company (NYSE:AXP), which I believe still has tremendous upside potential even after a gain of almost 30% so far this year. Just how much further could it go, and can the same be said for its competitors?

About American Express

One of the leading global payments and travel services companies, American Express Company (NYSE:AXP) offers its services to businesses and individuals all over the world. Its business is divided into four main segments.

American Express Company (NYSE:AXP)

U.S Card Services is the largest segment, and is responsible for just over half of the company’s revenues. This segment includes the U.S. consumer card business, the well-known Travelers Cheques business, the prepaid card business, and the travel network. International card services accounts for 17% of the company’s revenue and is made up of the cards issued to customers outside of the U.S. Global Network & Merchant Services (also 17% of revenues) deals with the company’s relationship with third-party issuers of American Express Company (NYSE:AXP) cards as well as the company’s relationship with merchants that accept American Express Cards. Finally, Global Commercial Services is the smallest segment at 15% of revenues and includes corporate American Express cards, corporate purchasing accounts, ePayment systems, and the American Express Business Travel activities.

Recent developments should lead to tremendous revenue growth

From a quick glance at the numbers above, one area where there is certainly room for growth is international. If 68% of the company’s revenue comes from both U.S. and international card services, a quick calculation reveals that 75% of the company’s card-related revenue is domestic.

Recently, the company has begun a few initiatives geared toward growing its domestic business. Last October, the company started a joint venture with Wal-Mart Stores, Inc. (NYSE:WMT), which created the prepaid “Bluebird” card. With the vast amount of consumers who shop at Wal-Mart, this venture should benefit both companies’ bottom lines. Consumers can add funds to their card via direct deposit, or by simply handing money to Wal-Mart Stores, Inc. (NYSE:WMT) cashiers, and is being marketed as an alternative to checking accounts and traditional debit cards.

Also, in March 2013 the company launched a “pay by tweet” joint venture with Twitter, which provides consumers with the opportunity to buy certain products by tweeting purchase hashtags. The company is using the service similar to a Groupon, where participating merchants offer a limited number of discounted products – such as an Amazon Kindle Fire HD for $149 – and works by synching a customer’s Amex account with their Twitter. American Express Company (NYSE:AXP) itself was among the first to offer a great deal, a $25 Amex gift card for $15. This service is available on a limited basis for now and has tons of room to grow.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!